Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]
Bosani M, Ardizzone S, Porro GB. Biologics: Targets and Therapy. 2009;3:77–97.This paper has been retracted after we were made aware that it contains a large amount of reused, and uncited material that was not placed within quotation marks.The following statement has been supplied by Dr S...
Guardado en:
Autores principales: | Bosani M, Ardizzone S, Porro GB |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1483e279d73b4d2dbeb521ac0c4d794a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biologic targeting in the treatment of inflammatory bowel diseases
por: Matteo Bosani, et al.
Publicado: (2009) -
Adalimumab for the treatment of Crohn’s disease
por: Andrea Cassinotti, et al.
Publicado: (2008) -
Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases
por: Marafini I, et al.
Publicado: (2020) -
Editorial: Game Changers in Inflammatory Bowel Diseases
por: Anita Bálint, et al.
Publicado: (2021) -
Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
por: Al Sulais E, et al.
Publicado: (2020)